VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 61,464
Sort by:

Plague Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Plague

US$ 1,200.00

Plague Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Plague Infection pipeline products. DISEASE OVERVIEW Plague infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Poliomyelitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Poliomyelitis

US$ 1,200.00

Poliomyelitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Poliomyelitis Infection pipeline products. DISEASE OVERVIEW Poliomyelitis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Pyelonephritis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Pyelonephritis

US$ 1,200.00

Pyelonephritis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Pyelonephritis Infection pipeline products. DISEASE OVERVIEW Pyelonephritis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Rhinovirus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Rhinovirus

US$ 1,200.00

Rhinovirus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Rhinovirus Infection pipeline products. DISEASE OVERVIEW Rhinovirus infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Schistosomiasis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Schistosomiasis

US$ 1,200.00

Schistosomiasis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Schistosomiasis Infection pipeline products. DISEASE OVERVIEW Schistosomiasis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Severe Acute Respiratory Syndrome (SARS) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Severe Acute Respiratory Syndrome (SARS)

US$ 1,200.00

... . SCOPE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) INFECTION PIPELINE REPORT INCLUDES Panorama of Severe Acute Respiratory Syndrome (SARS) Infection pipeline markets including statistics on therapeutic drugs and companies involved Severe Acute Respiratory Syndrome (SARS) Infection Pipeline ...

September 2018 65 pages

Shingles Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Shingles

US$ 1,200.00

Shingles Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Shingles Infection pipeline products. DISEASE OVERVIEW Shingles infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Tinea pedis (Athlete Foot) Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Tinea pedis (Athlete Foot)

US$ 1,200.00

... format. SCOPE OF TINEA PEDIS (ATHLETE FOOT) INFECTION PIPELINE REPORT INCLUDES Panorama of Tinea pedis (Athlete Foot) Infection pipeline markets including statistics on therapeutic drugs and companies involved Tinea pedis (Athlete Foot) Infection Pipeline candidates across ...

September 2018 65 pages

Toxoplasmosis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Toxoplasmosis

US$ 1,200.00

Toxoplasmosis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Toxoplasmosis Infection pipeline products. DISEASE OVERVIEW Toxoplasmosis infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

Warts Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Warts

US$ 1,200.00

Warts Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Warts Infection pipeline products. DISEASE OVERVIEW Warts infection is spread through Clostridium tetani bacteria, which ...

September 2018 65 pages

West Nile Virus Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for West Nile Virus

US$ 1,200.00

West Nile Virus Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of West Nile Virus Infection pipeline products. DISEASE OVERVIEW West Nile Virus infection is spread through Clostridium ...

September 2018 65 pages

Western Equine Encephalitis Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Western Equine Encephalitis

US$ 1,200.00

Western Equine Encephalitis Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Western Equine Encephalitis Infection pipeline products. DISEASE OVERVIEW Western Equine Encephalitis infection is spread through Clostridium ...

September 2018 65 pages

Achondroplasia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ACHONDROPLASIA PIPELINE REPORT INCLUDES Panorama of Achondroplasia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Acid Sphingomyelinase Deficiency (NPD C) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ACID SPHINGOMYELINASE DEFICIENCY (NPD C) PIPELINE REPORT INCLUDES Panorama of Acid Sphingomyelinase Deficiency (NPD C) pipeline markets including statistics on therapeutic drugs and companies involved Acid Sphingomyelinase Deficiency (NPD C) Pipeline candidates across ...

August 2018 60 pages

Acinetobacter Infections R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACINETOBACTER INFECTIONS PIPELINE REPORT INCLUDES Panorama of Acinetobacter Infections pipeline markets including statistics on therapeutic drugs and companies involved Acinetobacter Infections Pipeline candidates across various development ...

August 2018 120 pages

Acne Vulgaris R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACNE VULGARIS PIPELINE REPORT INCLUDES Panorama of Acne Vulgaris pipeline markets including statistics on therapeutic drugs and companies involved Acne Vulgaris Pipeline candidates across various development ...

August 2018 150 pages

Acromegaly R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ACROMEGALY PIPELINE REPORT INCLUDES Panorama of Acromegaly pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

Actinic (Solar) Keratosis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACTINIC (SOLAR) KERATOSIS PIPELINE REPORT INCLUDES Panorama of Actinic (Solar) Keratosis pipeline markets including statistics on therapeutic drugs and companies involved Actinic (Solar) Keratosis Pipeline candidates across various development ...

August 2018 50 pages

Acute Coronary Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACUTE CORONARY SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Coronary Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Coronary Syndrome Pipeline candidates across various development ...

August 2018 90 pages

Acute Heart Failure R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACUTE HEART FAILURE PIPELINE REPORT INCLUDES Panorama of Acute Heart Failure pipeline markets including statistics on therapeutic drugs and companies involved Acute Heart Failure Pipeline candidates across various development ...

August 2018 60 pages

Acute Ischemic Stroke R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACUTE ISCHEMIC STROKE PIPELINE REPORT INCLUDES Panorama of Acute Ischemic Stroke pipeline markets including statistics on therapeutic drugs and companies involved Acute Ischemic Stroke Pipeline candidates across various development ...

August 2018 100 pages

Acute Lung Injury R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACUTE LUNG INJURY PIPELINE REPORT INCLUDES Panorama of Acute Lung Injury pipeline markets including statistics on therapeutic drugs and companies involved Acute Lung Injury Pipeline candidates across various development ...

August 2018 80 pages

Acute Pain R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ACUTE PAIN PIPELINE REPORT INCLUDES Panorama of Acute Pain pipeline markets including statistics on therapeutic drugs and companies involved Acute Pain Pipeline candidates across various development ...

August 2018 160 pages

Acute Renal Failure (ARF) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ACUTE RENAL FAILURE (ARF) PIPELINE REPORT INCLUDES Panorama of Acute Renal Failure (ARF) pipeline markets including statistics on therapeutic drugs and companies involved Acute Renal Failure (ARF) Pipeline candidates across ...

August 2018 100 pages

Acute Respiratory Distress Syndrome R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ACUTE RESPIRATORY DISTRESS SYNDROME PIPELINE REPORT INCLUDES Panorama of Acute Respiratory Distress Syndrome pipeline markets including statistics on therapeutic drugs and companies involved Acute Respiratory Distress Syndrome Pipeline candidates across ...

August 2018 80 pages

Acute Sensorineural Hearing Loss R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ACUTE SENSORINEURAL HEARING LOSS PIPELINE REPORT INCLUDES Panorama of Acute Sensorineural Hearing Loss pipeline markets including statistics on therapeutic drugs and companies involved Acute Sensorineural Hearing Loss Pipeline candidates across ...

August 2018 40 pages

Adrenocortical Carcinoma (Adrenal Cortex Cancer) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ADRENOCORTICAL CARCINOMA (ADRENAL CORTEX CANCER) PIPELINE REPORT INCLUDES Panorama of Adrenocortical Carcinoma (Adrenal Cortex Cancer) pipeline markets including statistics on therapeutic drugs and companies involved Adrenocortical Carcinoma (Adrenal Cortex Cancer) Pipeline candidates across ...

August 2018 90 pages

Adrenoleukodystrophy R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ADRENOLEUKODYSTROPHY PIPELINE REPORT INCLUDES Panorama of Adrenoleukodystrophy pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 60 pages

African Trypanosomiasis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF AFRICAN TRYPANOSOMIASIS PIPELINE REPORT INCLUDES Panorama of African Trypanosomiasis pipeline markets including statistics on therapeutic drugs and companies involved African Trypanosomiasis Pipeline candidates across various development ...

August 2018 40 pages

Alcohol Addiction R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ALCOHOL ADDICTION PIPELINE REPORT INCLUDES Panorama of Alcohol Addiction pipeline markets including statistics on therapeutic drugs and companies involved Alcohol Addiction Pipeline candidates across various development ...

August 2018 110 pages

Alcoholic Hepatitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ALCOHOLIC HEPATITIS PIPELINE REPORT INCLUDES Panorama of Alcoholic Hepatitis pipeline markets including statistics on therapeutic drugs and companies involved Alcoholic Hepatitis Pipeline candidates across various development ...

August 2018 60 pages

Allergic Conjunctivitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ALLERGIC CONJUNCTIVITIS PIPELINE REPORT INCLUDES Panorama of Allergic Conjunctivitis pipeline markets including statistics on therapeutic drugs and companies involved Allergic Conjunctivitis Pipeline candidates across various development ...

August 2018 60 pages

Allergic Rhinitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ALLERGIC RHINITIS PIPELINE REPORT INCLUDES Panorama of Allergic Rhinitis pipeline markets including statistics on therapeutic drugs and companies involved Allergic Rhinitis Pipeline candidates across various development ...

August 2018 100 pages

Alopecia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ALOPECIA PIPELINE REPORT INCLUDES Panorama of Alopecia pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 120 pages

Alpha Antitrypsin Deficiency R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... comprehensive information of AlphaAntitrypsin Deficiency pipeline products. The AlphaAntitrypsin Deficiency pipeline guide presents complete ... use format. SCOPE OF ALPHA%LI%ANTITRYPSIN DEFICIENCY PIPELINE REPORT INCLUDES Panorama of AlphaAntitrypsin Deficiency pipeline markets including statistics on ...

August 2018 70 pages

Amyloidosis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF AMYLOIDOSIS PIPELINE REPORT INCLUDES Panorama of Amyloidosis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 150 pages

Anal Cancer R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANAL CANCER PIPELINE REPORT INCLUDES Panorama of Anal Cancer pipeline markets including statistics on therapeutic drugs and companies involved Anal Cancer Pipeline candidates across various development ...

August 2018 190 pages

Anaphylaxis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ANAPHYLAXIS PIPELINE REPORT INCLUDES Panorama of Anaphylaxis pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 30 pages

Anaplastic Astrocytoma R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANAPLASTIC ASTROCYTOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Astrocytoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Astrocytoma Pipeline candidates across various development ...

August 2018 130 pages

Anaplastic Large Cell Lymphoma R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... format. SCOPE OF ANAPLASTIC LARGE CELL LYMPHOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Large Cell Lymphoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Large Cell Lymphoma Pipeline candidates across ...

August 2018 80 pages

Anaplastic Oligoastrocytoma R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANAPLASTIC OLIGOASTROCYTOMA PIPELINE REPORT INCLUDES Panorama of Anaplastic Oligoastrocytoma pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Oligoastrocytoma Pipeline candidates across various development ...

August 2018 60 pages

Anaplastic Thyroid Cancer R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANAPLASTIC THYROID CANCER PIPELINE REPORT INCLUDES Panorama of Anaplastic Thyroid Cancer pipeline markets including statistics on therapeutic drugs and companies involved Anaplastic Thyroid Cancer Pipeline candidates across various development ...

August 2018 60 pages

Androgenic Alopecia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANDROGENIC ALOPECIA PIPELINE REPORT INCLUDES Panorama of Androgenic Alopecia pipeline markets including statistics on therapeutic drugs and companies involved Androgenic Alopecia Pipeline candidates across various development ...

August 2018 60 pages

Anesthetic Effect R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANESTHETIC EFFECT PIPELINE REPORT INCLUDES Panorama of Anesthetic Effect pipeline markets including statistics on therapeutic drugs and companies involved Anesthetic Effect Pipeline candidates across various development ...

August 2018 70 pages

Angina (Angina Pectoris) R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANGINA (ANGINA PECTORIS) PIPELINE REPORT INCLUDES Panorama of Angina (Angina Pectoris) pipeline markets including statistics on therapeutic drugs and companies involved Angina (Angina Pectoris) Pipeline candidates across various development ...

August 2018 60 pages

Ankylosing Spondylitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF ANKYLOSING SPONDYLITIS PIPELINE REPORT INCLUDES Panorama of Ankylosing Spondylitis pipeline markets including statistics on therapeutic drugs and companies involved Ankylosing Spondylitis Pipeline candidates across various development ...

August 2018 160 pages

Anthrax R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ANTHRAX PIPELINE REPORT INCLUDES Panorama of Anthrax pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 90 pages

Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... . SCOPE OF ANTI NEUTROPHIL CYTOPLASMIC ANTIBODY ASSOCIATED VASCULITIS PIPELINE REPORT INCLUDES Panorama of Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis pipeline markets including statistics on therapeutic drugs and companies involved Anti Neutrophil Cytoplasmic Antibody Associated Vasculitis ...

August 2018 70 pages

Aplastic Anemia R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... to use format. SCOPE OF APLASTIC ANEMIA PIPELINE REPORT INCLUDES Panorama of Aplastic Anemia pipeline markets including statistics on therapeutic drugs and companies involved Aplastic Anemia Pipeline candidates across various development ...

August 2018 60 pages

Arrhythmias R&D Pipeline Analysis Report, H2-2018

US$ 2,200.00

... is presented in user friendly and ready to use format. SCOPE OF ARRHYTHMIAS PIPELINE REPORT INCLUDES Panorama of Arrhythmias pipeline markets including statistics on therapeutic drugs and companies involved ...

August 2018 40 pages

Filters

Search

Categories

1,428
60
12,968
1,223
4,429
2
1
12,593
2,818
15,138
67
8,921
1
1,229
586

Publishers

61,464

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
61,427

Price

Date

Pages

Offers